Health & Fitness
Health and Fitness
Health and Fitness
Wed, August 4, 2010
Tue, August 3, 2010 NeuroMetrix, Inc. Announces Date for 2010 Second Quarter Financial Results Conference Call
WALTHAM, Mass.--([ BUSINESS WIRE ])--NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2010 second quarter financial results before the opening of the market on Tuesday, August 10, 2010. The Company will host a conference call and webcast at 8:00 A.M. Eastern time on August 10, 2010 to discuss its second quarter financial results as well as business developments affecting the Company.
The conference call may be accessed in the United States by dialing 866-314-5232 and using the confirmation code 96808464. Internationally, the conference call may be accessed by dialing 617-213-8052 and using the same confirmation code. The webcast, along with the earnings press release and accompanying condensed financial statements, will be accessible from the Company's website at [ www.neurometrix.com ] under the "Investors" tab.
A replay of the conference call will be available starting two hours after the call by dialing 888-286-8010, domestically and 617-801-6888, internationally. The confirmation code to access the replay is 47777177. The replay will be available for three months after the conference call.
About NeuroMetrix
NeuroMetrix is a science-based health care company transforming patient care through neurotechnology. We provide innovative products for preservation and restoration of nerve and spinal cord function, and pain control. To date, our focus has been primarily on the assessment of neuropathies. Neuropathies affect the peripheral nerves and parts of the spine and are frequently caused by or associated with carpal tunnel syndrome, diabetes, sciatica, and other clinical disorders. We market systems for the performance of nerve conduction studies and needle electromyography procedures. Our product pipeline includes a system designed to deliver pharmacologic agents such as anesthetics and corticosteroids in close proximity to nerves for regional anesthesia, pain control and the treatment of focal neuropathies. We are also developing devices and pharmaceutical agents to treat spinal cord injuries. For more information, visit [ http://www.neurometrix.com ].
